Press "esc" to clear
Go to Advanced Search

Showing results

110 of 777
unnamed4.jpg
  • Embargo expired:
    15-Jan-2019 2:00 PM EST

Article ID: 706154

Back to the future with CD4 testing: improving HIV care in low- and middle-income countries

PLOS

A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of lives, according to an Essay published January 15 in the open-access journal PLOS Medicine by Mark Tenforde of the University of Washington School of Medicine, and colleagues.

Released:
8-Jan-2019 2:00 PM EST
IMG_1661.JPG

Article ID: 706327

UCLA researchers correct genetic mutation that causes IPEX, a life-threatening autoimmune syndrome

University of California, Los Angeles (UCLA), Health Sciences

UCLA researchers led by Dr. Donald Kohn have created a method for modifying blood stem cells to reverse the genetic mutation that causes a life-threatening autoimmune syndrome called IPEX.

Released:
10-Jan-2019 4:05 PM EST
20181218_MM_Imai233-700x467.jpg
  • Embargo expired:
    7-Jan-2019 11:00 AM EST

Article ID: 706037

Scientists identify new fuel-delivery route for cells

Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have identified a previously unknown route for cellular fuel delivery, a finding that could shed light on the process of aging and the chronic diseases that often accompany it.

Released:
4-Jan-2019 3:05 PM EST

Article ID: 706066

Faulty immune receptor could be reason why many face HIV complications

Michigan State University

MSU scientists have discovered SLAMF7, an immune receptor, has the ability to tone down the body’s immune response when activated on certain white blood cells. Yet, for certain HIV patients who experience a myriad of health issues, the researchers found that these patients’ receptors don’t work properly.

Released:
7-Jan-2019 10:05 AM EST
DavidFajgenbaum.jpg

Article ID: 705964

What’s Next After a Landmark Year for Castleman Disease Research

Perelman School of Medicine at the University of Pennsylvania

When researchers unlock the mysteries of Castleman disease, they may single out 2018 as one of the years in which they laid the foundation to help them turn the key, and the University of Pennsylvania has been the epicenter.

Released:
3-Jan-2019 11:05 AM EST

Article ID: 705701

American Neurological Association announces 2018’s most-accessed journal articles

American Neurological Association (ANA)

The American Neurological Association (ANA), the professional organization representing the nation’s top academic neurologists and neuroscientists, today released a list of the most-accessed articles of 2018 in its Annals of Neurology and Annals of Clinical & Translational Neurology (ACTN).

Released:
20-Dec-2018 8:30 AM EST
unnamed.jpg
  • Embargo expired:
    13-Dec-2018 2:00 PM EST

Article ID: 704976

Control HIV by treating schistosomiasis, new study suggests

PLOS

Of the 34 million people worldwide with HIV, and the 200 million with schistosomiasis, the majority live in Africa— where millions of people are simultaneously infected with both diseases. Now, researchers reporting in PLOS Neglected Tropical Diseases have shown that schistosomiasis infections are associated with increased HIV onward transmission, HIV acquisition in HIV negative women with urogenital schistosomiasis, and progression to death in HIV positive women.

Released:
5-Dec-2018 12:45 PM EST

Article ID: 705292

The Weizmann Institute of Science Establishes the Dr. Barry Sherman Institute for Medicinal Chemistry

Weizmann Institute of Science

The new Sherman Institute will advance basic research on novel therapies for a range of disorders, including autoimmune, neurodegenerative, and infectious diseases, as well as cancer.

Released:
11-Dec-2018 5:05 PM EST
  • Embargo expired:
    5-Dec-2018 8:00 AM EST

Article ID: 704910

New research highlights why HIV-infected patients suffer higher rates of cancer than general population

Case Western Reserve University

AIDS patients suffer higher rates of cancer because they have fewer T-cells in their bodies to fight disease. But new research examines why HIV-infected patients have higher rates of cancer—among the leading causes of death among that population—than the general population.

Released:
5-Dec-2018 8:00 AM EST

Showing results

110 of 777

Chat now!